Can Chen Selected Research

Can Chen Research Topics

Disease

33	Neoplasms (Cancer) 10/2022 - 01/2011
11	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2014
9	Hypoxia (Hypoxemia) 01/2022 - 01/2014
9	Myocardial Infarction 12/2019 - 12/2010
8	Inflammation (Inflammations) 03/2022 - 01/2015
7	COVID-19 01/2022 - 08/2020
6	Breast Neoplasms (Breast Cancer) 03/2020 - 05/2012
5	Thrombosis (Thrombus) 03/2022 - 10/2018
5	Carcinogenesis 01/2022 - 09/2017
5	Infections 08/2020 - 01/2014
5	Coronary Artery Disease (Coronary Atherosclerosis) 01/2020 - 01/2016
4	Necrosis 11/2022 - 07/2010
4	Wounds and Injuries (Trauma) 08/2022 - 03/2014
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 09/2014
4	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 01/2016
4	Pulmonary Arterial Hypertension 01/2017 - 09/2014
3	Infarction (Infarctions) 11/2022 - 12/2010
3	Hypertension (High Blood Pressure) 10/2022 - 12/2012
3	Atherosclerosis 03/2022 - 01/2015
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2022 - 04/2018
3	Thrombocytopenia (Thrombopenia) 03/2022 - 09/2020
3	Endometrial Neoplasms (Endometrial Cancer) 01/2021 - 01/2020
2	Atrial Fibrillation 10/2022 - 12/2019
2	Pathologic Constriction (Stenosis) 06/2022 - 12/2020
2	Kidney Diseases (Kidney Disease) 03/2022 - 04/2020
2	Multiple Myeloma 01/2022 - 12/2020
2	Hepatitis B 01/2022 - 09/2021
2	Human Influenza (Influenza) 10/2021 - 01/2020
2	Parkinson Disease (Parkinson's Disease) 02/2021 - 07/2020
2	Cytokine Release Syndrome 01/2021 - 01/2020
2	Obesity 01/2021 - 01/2016
2	Heart Diseases (Heart Disease) 01/2021 - 12/2015
2	Glioblastoma (Glioblastoma Multiforme) 09/2020 - 01/2011
2	Hemorrhage 01/2020 - 01/2014
2	Acute Coronary Syndrome 04/2018 - 01/2016
2	Glioma (Gliomas) 10/2016 - 01/2011
2	Virus Diseases (Viral Diseases) 01/2016 - 06/2015
1	Rupture 11/2022
1	Acne Vulgaris 10/2022
1	Heart Failure 10/2022

Drug/Important Bio-Agent (IBA)

9	RNA (Ribonucleic Acid)IBA 01/2022 - 02/2017
9	Biomarkers (Surrogate Marker)IBA 04/2021 - 11/2014
8	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2013
6	Interleukin-6 (Interleukin 6)IBA 11/2022 - 01/2014
6	Biological ProductsIBA 10/2022 - 08/2013
6	CytokinesIBA 01/2021 - 01/2016
5	Pharmaceutical PreparationsIBA 01/2022 - 10/2014
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 01/2014
5	Messenger RNA (mRNA)IBA 01/2022 - 01/2019
5	Chimeric Antigen ReceptorsIBA 01/2022 - 01/2016
5	MicroRNAs (MicroRNA)IBA 03/2020 - 09/2014
4	Long Noncoding RNAIBA 01/2022 - 09/2017
4	DNA (Deoxyribonucleic Acid)IBA 09/2021 - 10/2013
3	CreatinineIBA 10/2022 - 12/2018
3	poly(lactide) (polylactic acid)IBA 03/2022 - 10/2018
3	Hepatitis B e AntigensIBA 01/2022 - 09/2021
3	Zoledronic Acid (Zometa)FDA Link 01/2022 - 01/2018
3	CateninsIBA 01/2021 - 06/2016
3	InterferonsIBA 01/2021 - 08/2014
3	InterleukinsIBA 11/2020 - 01/2016
3	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2018 - 10/2014
2	Troponin IIBA 11/2022 - 01/2022
2	Transforming Growth Factors (Transforming Growth Factor)IBA 04/2022 - 12/2019
2	CurcuminIBA 03/2022 - 12/2019
2	fibrin fragment D (D-dimer)IBA 01/2022 - 11/2020
2	ProcalcitoninIBA 01/2022 - 12/2018
2	6-methyladenineIBA 01/2022 - 01/2022
2	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2020
2	Anti-Bacterial Agents (Antibiotics)IBA 11/2021 - 12/2020
2	Immunoglobulins (Immunoglobulin)IBA 09/2021 - 03/2018
2	AnticoagulantsIBA 06/2021 - 08/2020
2	Nerve Growth Factor (NGF)IBA 01/2021 - 12/2010
2	Immune Checkpoint InhibitorsIBA 01/2021 - 09/2020
2	Oxygen (Dioxygen)IBA 01/2021 - 11/2016
2	ResveratrolIBA 01/2021 - 12/2010
2	Transcription Factors (Transcription Factor)IBA 01/2021 - 06/2016
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2020 - 08/2014
2	LigandsIBA 06/2020 - 12/2015
2	p38 Mitogen-Activated Protein KinasesIBA 12/2019 - 11/2019
2	C-Reactive ProteinIBA 12/2018 - 12/2015
2	QuercetinIBA 01/2017 - 03/2012
2	Caspase 3 (Caspase-3)IBA 10/2016 - 08/2014
2	Interleukin-12 Subunit p35IBA 01/2016 - 01/2016
2	baicalinIBA 12/2015 - 10/2014
2	CD40 Ligand (CD40L)IBA 08/2014 - 08/2014
2	LipidsIBA 06/2014 - 01/2014
1	Hematoxylin (Haematoxylon)IBA 11/2022
1	MB Form Creatine KinaseIBA 11/2022
1	Eosine Yellowish-(YS) (Eosin)IBA 11/2022
1	ChloridesIBA 11/2022
1	sacubitril and valsartan sodium hydrate drug combinationIBA 10/2022
1	Brain Natriuretic Peptide (Natrecor)FDA Link 10/2022
1	Interleukin-1 (Interleukin 1)IBA 10/2022

Therapy/Procedure

19	Therapeutics 01/2022 - 01/2011
5	Stents 06/2022 - 10/2018
5	Drug Therapy (Chemotherapy) 01/2022 - 09/2017
2	Immunotherapy 01/2022 - 02/2017
2	Radiotherapy 01/2021 - 01/2014
2	Punctures 12/2019 - 03/2018
1	Noninvasive Ventilation 11/2022